In last trading session, Ampio Pharmaceuticals Inc. (AMEX:AMPE) saw 10.32 million shares changing hands with its beta currently measuring 1.75. Company’s recent per share price level of $0.08 trading at $0.0 or -3.00% at ring of the bell on the day assigns it a market valuation of $18.41M. That closing price of AMPE’s stock is at a discount of -2175.0% from its 52-week high price of $1.82 and is indicating a premium of 12.5% from its 52-week low price of $0.07. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 8.85 million shares which gives us an average trading volume of 7.97 million if we extend that period to 3-months.
For Ampio Pharmaceuticals Inc. (AMPE), analysts’ consensus is at an average recommendation of a Hold while assigning it a mean rating of 3.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 0 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -$0.02 in the current quarter.
Ampio Pharmaceuticals Inc. (AMEX:AMPE) trade information
Upright in the red during last session for losing -3.00%, in the last five days AMPE remained trading in the red while hitting it’s week-highest on Thursday, 09/15/22 when the stock touched $0.08 price level, adding 21.57% to its value on the day. Ampio Pharmaceuticals Inc.’s shares saw a change of -86.39% in year-to-date performance and have moved -19.59% in past 5-day. Ampio Pharmaceuticals Inc. (AMEX:AMPE) showed a performance of -14.35% in past 30-days. Number of shares sold short was 13.06 million shares which calculate 2.33 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of $2.00 to the stock, which implies a rise of 96.0% to its current value. Analysts have been projecting $2.00 as a low price target for the stock while placing it at a high target of $2.00. It follows that stock’s current price would drop -2400.0% in reaching the projected high whereas dropping to the targeted low would mean a loss of -2400.0% for stock’s current value.
Ampio Pharmaceuticals Inc. (AMPE) estimates and forecasts
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 24.80% during past 5 years.
Ampio Pharmaceuticals Inc. is more likely to be releasing its next quarterly report between March 01 and March 07 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
Ampio Pharmaceuticals Inc. (AMEX:AMPE)’s Major holders
Insiders are in possession of 7.64% of company’s total shares while institution are holding 21.67 percent of that, with stock having share float percentage of 23.46%. Investors also watch the number of corporate investors in a company very closely, which is 21.67% institutions for Ampio Pharmaceuticals Inc. that are currently holding shares of the company. Blackrock Inc. is the top institutional holder at AMPE for having 14.0 million shares of worth $6.58 million. And as of Mar 30, 2022, it was holding 6.19% of the company’s outstanding shares.
The second largest institutional holder is Vanguard Group, Inc. (The), which was holding about 9.31 million shares on Mar 30, 2022. The number of shares represents firm’s hold over 4.11% of outstanding shares, having a total worth of $4.37 million.
On the other hand, Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Mar 30, 2022, the former fund manager was holding 5.32 million shares of worth $2.5 million or 2.35% of the total outstanding shares. The later fund manager was in possession of 2.59 million shares on Mar 30, 2022, making its stake of worth around $1.22 million in the company or a holder of 1.14% of company’s stock.